OMINQ Secures Over $1 Million in New Purchase Orders from Prominent Bioscience Company
OMNIQ Corp. (OTCQB: OMQS) has secured over $1 million in new purchase orders from a long-term bioscience customer, marking a 20-year partnership milestone. This follows a recent $2.5 million order from a major retail chain. The new orders include advanced scanning technology to replace legacy equipment and support the customer's growth. OMNIQ's CEO, Shai Lustgarten, emphasized the company's commitment to delivering state-of-the-art technologies for the bioscience industry.
This announcement builds on OMNIQ's recent strategic collaborations with Ingenico and SHVA, enhancing its global footprint. The company's AI-driven solutions are designed to optimize operational processes across various industries, including healthcare, logistics, and bioscience, providing enhanced data capture capabilities, greater accuracy, and increased processing speeds.
OMNIQ Corp. (OTCQB: OMQS) ha ottenuto oltre 1 milione di dollari in nuovi ordini di acquisto da un cliente nel settore delle bioscienze con cui ha una partnership ventennale. Questo avviene dopo un ordine di 2,5 milioni di dollari da una grande catena di distribuzione. I nuovi ordini comprendono tecnologie di scansione avanzate per sostituire le attrezzature obsolete e supportare la crescita del cliente. Il CEO di OMNIQ, Shai Lustgarten, ha sottolineato l'impegno dell'azienda nel fornire tecnologie all'avanguardia per l'industria delle bioscienze.
Questo annuncio si aggiunge alle recenti collaborazioni strategiche di OMNIQ con Ingenico e SHVA, ampliando la sua presenza globale. Le soluzioni basate sull'intelligenza artificiale dell'azienda sono progettate per ottimizzare i processi operativi in vari settori, tra cui sanità, logistica e bioscienza, offrendo capacità di acquisizione dati migliorate, maggiore precisione e velocità di elaborazione aumentate.
OMNIQ Corp. (OTCQB: OMQS) ha asegurado más de 1 millón de dólares en nuevos órdenes de compra de un cliente a largo plazo en el ámbito de las biosciencias, marcando un hito de 20 años de asociación. Esto sigue a un reciente pedido de 2,5 millones de dólares de una importante cadena minorista. Los nuevos pedidos incluyen tecnología de escaneo avanzada para reemplazar equipos obsoletos y apoyar el crecimiento del cliente. El CEO de OMNIQ, Shai Lustgarten, enfatizó el compromiso de la empresa de ofrecer tecnologías de última generación para la industria de las biosciencias.
Este anuncio se basa en las recientes colaboraciones estratégicas de OMNIQ con Ingenico y SHVA, mejorando su presencia global. Las soluciones impulsadas por inteligencia artificial de la compañía están diseñadas para optimizar procesos operativos en diversas industrias, incluida la salud, la logística y las biosciencias, proporcionando capacidades de captura de datos mejoradas, mayor precisión y velocidades de procesamiento incrementadas.
OMNIQ Corp. (OTCQB: OMQS)는 백만 달러 이상의 신규 구매 주문을 확보했습니다, 20년의 파트너십 이정표를 기록하며 장기 바이오 과학 고객으로부터 받았습니다. 이는 최근 2.5백만 달러의 대형 소매 체인으로부터의 주문에 이어지는 것입니다. 새로운 주문에는 기존 장비를 대체하고 고객의 성장을 지원하기 위한 첨단 스캔 기술이 포함되어 있습니다. OMNIQ의 CEO인 샤이 루스트가르텐은 바이오 과학 산업을 위한 최첨단 기술을 제공하겠다는 회사의 의지를 강조했습니다.
이 발표는 OMNIQ의 Ingenico 및 SHVA와의 최근 전략적 협업을 기반으로 하여 글로벌 입지를 강화하고 있습니다. 회사의 AI 기반 솔루션은 의료, 물류 및 바이오 과학을 포함한 다양한 산업의 운영 프로세스를 최적화하도록 설계되어 데이터 수집 기능을 향상시키고 정확성을 높이며 처리 속도를 증가시킵니다.
OMNIQ Corp. (OTCQB: OMQS) a sécurisé plus d'un million de dollars en nouvelles commandes d'achat d'un client à long terme dans le secteur des biosciences, marquant une étape dans une partenariat de 20 ans. Cela fait suite à une commande de 2,5 millions de dollars d'une grande chaîne de distribution. Les nouvelles commandes incluent des technologies de scan avancées pour remplacer l'équipement obsolète et soutenir la croissance du client. Le PDG d'OMNIQ, Shai Lustgarten, a souligné l'engagement de l'entreprise à fournir des technologies de pointe pour l'industrie des biosciences.
Cette annonce s'inscrit dans le cadre des récentes collaborations stratégiques d'OMNIQ avec Ingenico et SHVA, renforçant ainsi sa présence mondiale. Les solutions basées sur l'IA de l'entreprise sont conçues pour optimiser les processus opérationnels à travers diverses industries, y compris la santé, la logistique et les biosciences, offrant des capacités de capture de données améliorées, une plus grande précision et des vitesses de traitement accrues.
OMNIQ Corp. (OTCQB: OMQS) hat über 1 Million Dollar an neuen Bestellungen gesichert von einem langfristigen Kunden in der Bioscience-Branche und damit einen Meilenstein in einer 20-jährigen Partnerschaft erreicht. Dies folgt auf eine kürzliche Bestellung über 2,5 Millionen Dollar von einer großen Einzelhandelskette. Die neuen Bestellungen umfassen fortschrittliche Scantechnologie zur Ersetzung veralteter Geräte und zur Unterstützung des Wachstums des Kunden. Der CEO von OMNIQ, Shai Lustgarten, betonte das Engagement des Unternehmens, modernste Technologien für die Bioscience-Industrie bereitzustellen.
Diese Ankündigung baut auf den jüngsten strategischen Kooperationen von OMNIQ mit Ingenico und SHVA auf und erweitert die globale Präsenz des Unternehmens. Die KI-gesteuerten Lösungen des Unternehmens sind darauf ausgelegt, betriebliche Prozesse in verschiedenen Branchen, darunter Gesundheitswesen, Logistik und Bioscience, zu optimieren, indem sie verbesserte Datenaufnahmefähigkeiten, höhere Genauigkeit und erhöhte Verarbeitungsgeschwindigkeiten bieten.
- Secured over $1 million in new purchase orders from a long-term bioscience customer
- Recently received a $2.5 million purchase order from a major retail chain
- Maintaining a 20-year partnership with a key bioscience customer
- Expanding product offerings with advanced scanning technology
- Strategic collaborations with Ingenico and SHVA enhancing global footprint
- None.
- Follows a
$2.5 Million Purchase Order from a Major Retail Chain: Reinforcing OMNIQ’s role in transforming retail operations with innovative AI-driven solutions. - 20-Year Partnership Milestone: These orders underscore the continuation of a two-decade-long relationship with a key bioscience customer.
- Strategic Collaborations with Ingenico and SHVA: This announcement builds on recent agreements with new partners, enhancing OMNIQ’s global footprint and technological offerings.
SALT LAKE CITY, Sept. 11, 2024 (GLOBE NEWSWIRE) -- OMNIQ Corp. (OTCQB: OMQS) (“OMNIQ” or “the Company”), a leading provider of AI-based technology solutions, today announced the receipt of new purchase orders totaling over
This development underscores OMNIQ’s continuing commitment to providing innovative solutions tailored to the evolving needs of its clients in the bioscience sector. The recent purchase includes the deployment of advanced scanners designed to enhance operational efficiency and accuracy, aligning with the customer's focus on staying at the forefront of bioscience innovation. In addition to refreshing equipment, the customer has seen notable growth, requiring them to purchase additional units.
Shai Lustgarten, CEO of OMNIQ, commented, “We are honored by the continued trust and confidence placed in us by our long-standing partner. This significant purchase order highlights the strength of our 20-year relationship and our commitment to delivering state-of-the-art technologies that support the critical work of the bioscience industry. As our partner embarks on a new phase of innovation, we are proud to contribute to their success with advanced scanning solutions.”
OMNIQ’s AI-driven products and solutions have a proven track record in optimizing operational processes across a variety of industries, including healthcare, logistics, and bioscience. The newly introduced equipment will provide the bioscience company with enhanced data capture capabilities, greater accuracy, and increased processing speeds—critical factors in maintaining high performance and regulatory compliance in the bioscience sector.
About OMNIQ
OMNIQ Corp. (OTCQB: OMQS) provides computerized and machine vision image processing solutions that use patented and proprietary AI technology to deliver real time object identification, tracking, surveillance, and monitoring for the Supply Chain Management, Public Safety, and Traffic Management applications. The technology and services provided by the Company help clients move people, objects, and manage big data safely and securely through airports, warehouses, schools, and national borders and in many other applications and environments.
OMNIQ’s customers include government agencies and leading Fortune 500 companies from several sectors, including manufacturing, retail, distribution, food and beverage, transportation and logistics, healthcare, and oil, gas, and chemicals. Since 2014, annual revenues have more than doubled, reaching
The Company currently addresses several billion-dollar markets with double-digit growth, including the Global Smart City & Public Safety markets.
For more information visit www.omniq.com
Forward-Looking Statements
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995. Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
This release contains “forward-looking statements” that include information relating to future events and future financial and operating performance. The words “anticipate,” “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.
Examples of forward-looking statements include, among others, statements made in this press release regarding the closing of the private placement and the use of proceeds received in the private placement. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for the Company’s products particularly during the current health crisis, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, the Company’s ability to manage credit and debt structures from vendors, debt holders and secured lenders, the Company’s ability to successfully integrate its acquisitions, and other information that may be detailed from time-to-time in OMNIQ Corp.’s filings with the United States Securities and Exchange Commission. Examples of such forward-looking statements in this release include, among others, statements regarding revenue growth, driving sales, operational and financial initiatives, cost reduction and profitability, and simplification of operations. For a more detailed description of the risk factors and uncertainties affecting OMNIQ Corp., please refer to the Company’s recent Securities and Exchange Commission filings, which are available at SEC.gov. OMNIQ Corp. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless otherwise required by law.
Contact IR@omniq.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9b131c3c-c08a-4653-896f-98968027cd75
FAQ
What is the value of the new purchase orders OMNIQ (OMQS) received from the bioscience company?
How long has OMNIQ (OMQS) been in partnership with the bioscience customer?
What type of technology is OMNIQ (OMQS) providing to the bioscience customer?
What other significant order did OMNIQ (OMQS) recently receive?
